Anup Ghimire

Mr. Anup Ghimire

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 June 2022 in American Journal of Infection Control
Verified
Journal Article
Closed access
SGSubarna Giri
Subarna Giri
AGAnup Ghimire
Anup Ghimire
AMAshish Mishra
Ashish Mishra
KAKshitiz Acharya
Kshitiz Acharya
SKSandip Kuikel
Sandip Kuikel
SMShyam Kumar Mishra
Shyam Kumar Mishra

24 March 2022 in Journal of Clinical Laboratory Analysis
Verified
Journal Article
Open access
AGAnup Ghimire
Anup Ghimire
SGSubarna Giri
Subarna Giri
NKNiharika Khanal
Niharika Khanal
SRShivani Rayamajhi
Shivani Rayamajhi
ATAnjila Thapa
Anjila Thapa
SDSurya Devkota
Surya Devkota
Purpose: We tried to investigate the diagnostic accuracy of glycogen phosphorylase BB as a cardiac marker for myocardial infarction.Methods: We searched through different electronic databases (PubMed, Google‐scholar, Embase, and Cochrane Library) to locate relevant articles. Studies, with sufficient data to reconstruct a 2 × 2 contingency table, met our inclusion criteria were included. Three reviewers independently screened the articles. Discrepancies were resolved by other reviewers. Unpublished data were requested from the authors of the study via email. Subsequently, data extraction was done using a standardized form and quality assessment of studies using the QUADAS‐2 tool. Meta‐analysis was done using a bivariate model using R software.Results: Fourteen studies were selected for the final evaluation, which yielded the summary points: pooled sensitivity 87.77% (77.52%–93.72%, I2 = 86%), pooled specificity 88.45% (75.59%–94.99%, I2 = 88%), pooled DOR 49.37(14.53–167.72, I2 = 89%), and AUC of SROC was 0.923. The lambda value of the HSROC curve was 3.670. The Fagan plot showed that GPBB increases the pretest probability of myocardial infarction from 46% to 81% when positive, and it lowers the same probability to 12% when negative.Conclusion: With these results, we can conclude that GPBB has modest accuracy in screening myocardial infarction, but the limitations of the study warrant further high‐quality studies to confirm its usefulness in predicting myocardial infarction (MI).

1 February 2024 in Journal of Clinical Neuroscience
Verified
Journal Article
Closed access
AGAnup Ghimire
Anup Ghimire
BKBijay Kunwar
Bijay Kunwar
BABinay Aryal
Binay Aryal
AGArjun Gaire
Arjun Gaire
ABAnil Bist
Anil Bist
BGBikram Prasad Gajurel
Bikram Prasad Gajurel

28 February 2024 in Annals of Medicine & Surgery
Verified
Journal Article
Open access
SBSamikchhya Keshary Mbbs Bhandari
Samikchhya Keshary Mbbs Bhandari
ABAnil Mbbs Bist
Anil Mbbs Bist
AGAnup Ghimire
Anup Ghimire
Background: Single breath count test (SBCT) may be a reproducible, rapid, easy to perform and easy to interpret substitute to spirometry especially in low resource settings for certain conditions. Its interest has been rekindled with the recent COVID-19 pandemic and it can be done as a part of tele-medicine as well. Objectives: The objective of this review was to summarize the evidence of SBCT in clinical practice. Methods: The authors searched EMBASE, PubMed and Google Scholar for all the relevant articles as per exclusion and inclusion criteria. Two authors independently screened all the studies. Newcastle Ottawa Scale was used to assess the quality of the studies. The systematic review was carried following the PRISMA guidelines. Results: After the rigorous process of screening, a total of 13 articles qualified for the systematic review. SBCT greater than 25 had sensitivity of greater than 80% in diagnosing myasthenia gravis exacerbation and SBCT less than or equal to 5 predicted the need for mechanical ventilation in Guillain–Barre syndrome (GBS) patients with 95.2% specificity. Also, Single breath count correlated significantly with forced expiratory volume in 1 sec (FEV1) and forced vital capacity (FVC) in children with pulmonary pathology and in patients with COVID-19 it was used to rule out the need for noninvasive respiratory support. Conclusion: SBCT will undoubtedly be an asset in low resource settings and in tele-medicine to assess the prognosis and guide management of different respiratory and neuromuscular diseases.

21 March 2022 in Clinical and Experimental Neuroimmunology
Verified
Journal Article
Closed access
PLPrajjwol Luitel
Prajjwol Luitel
AGAnup Ghimire
Anup Ghimire
DUDevansh Upadhyay
Devansh Upadhyay
RORajeev Ojha
Rajeev Ojha

7 February 2026 in BMC Endocrine Disorders
Verified
Journal Article
Open access
STSaurav Thapa
Saurav Thapa
AGAnup Ghimire
Anup Ghimire
BKBijay Kunwar
Bijay Kunwar
BABinay Aryal
Binay Aryal
AAAramva Bikram Adhikari
Aramva Bikram Adhikari
MGMani Prasad Gautam
Mani Prasad Gautam
Background: Diabetic retinopathy (DR) is one of the most important microvascular complications of diabetes mellitus and remains a major cause of preventable blindness worldwide. Insulin resistance plays a pivotal role in the development of diabetes and its associated complications. The triglyceride–glucose (TyG) index, a surrogate marker of insulin resistance derived from fasting plasma glucose and triglyceride levels, has gained attention as a simple and practical metabolic marker. However, data linking the TyG index with diabetic retinopathy, particularly in South Asian populations, are still limited. Methods: A hospital-based cross-sectional study was conducted at Bir Hospital, Kathmandu, Nepal, between April 2023 and October 2024. Adult patients with diabetes mellitus, excluding those with gestational diabetes, acute illness, non-diabetic causes of hypertriglyceridaemia, conditions affecting lipid or glucose metabolism, prior retinal interventions, or non-diabetic retinal diseases, underwent comprehensive clinical, biochemical, and ophthalmic evaluations. The triglyceride–glucose (TyG) index was calculated as ln [fasting triglycerides (mg/dL) × fasting plasma glucose (mg/dL) / 2], and participants were categorized into quartiles. Diabetic retinopathy was graded using internationally accepted clinical severity scales. Associations were assessed using univariate and multivariate logistic regression, and ROC curve analysis evaluated the discriminatory performance of the TyG index. Results: Among 83 patients with diabetes mellitus (median age 56 years [IQR 48.5–64], 50.6% male, median diabetes duration 6 years [IQR 3–12]), the median triglyceride-glucose (TyG) index was 9.98 (IQR 9.485–10.445). Diabetic retinopathy (DR) prevalence was 48.2%, increasing across TyG quartiles from 9.5% in Q1 to 85.7% in Q4 ( p < 0.001), with a significant trend in DR severity ( p < 0.001). TyG correlated moderately with HbA1c (Spearman r = 0.54, p < 0.001). In multivariable logistic regression adjusted for age, total cholesterol, and HDL, the odds ratio for DR per standard deviation increase in TyG was 4.00 (95% CI 1.75–9.16, p = 0.001); for Q4 vs. Q1, 24.15 (95% CI 3.15–185, p = 0.002). Findings were robust in sensitivity analyses excluding insulin users (OR 4.35, 95% CI 1.40–13.5, p = 0.011) and outliers (OR 3.80, 95% CI 1.60-9.00, p = 0.002), and stratified by diabetes duration (≥ 5 years: OR 5.20, 95% CI 1.80–15.0, p = 0.002) and sex (males: OR 3.80, 95% CI 1.20–12.0, p = 0.023; females: OR 4.50, 95% CI 1.30–15.5, p = 0.017). TyG predicted DR with an area under the ROC curve of 0.83 (95% CI 0.75–0.91), comparable to HbA1c (0.77, DeLong p = 0.29); optimal cutoff 9.78 (sensitivity 88%, specificity 67%). Conclusions: A higher triglyceride–glucose index was strongly associated with both the presence and severity of diabetic retinopathy. Given its simplicity and reliance on routinely available laboratory parameters, the TyG index may be a useful marker for identifying diabetic patients at increased risk of retinopathy, particularly in resource-limited settings. Clinical trial registration: Not applicable. This was a cross-sectional observational study and did not involve a clinical trial requiring registration.